Works matching IS 25094254 AND DT 2023 AND VI 7 AND IP 6
Results: 13
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 997, doi. 10.1007/s41669-023-00444-9
- By:
- Publication type:
- Article
Trade-Offs between Vaccine Effectiveness and Vaccine Safety: Personal versus Policy Decisions.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 915, doi. 10.1007/s41669-023-00442-x
- By:
- Publication type:
- Article
Estimating Cumulative Health Care Costs of Childhood and Adolescence Autism Spectrum Disorder in Ontario, Canada: A Population-Based Incident Cohort Study.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 987, doi. 10.1007/s41669-023-00441-y
- By:
- Publication type:
- Article
Cost-Effectiveness of Non-pharmacological Interventions for Mild Cognitive Impairment and Dementia: A Systematic Review of Economic Evaluations and a Review of Reviews.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 887, doi. 10.1007/s41669-023-00440-z
- By:
- Publication type:
- Article
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 863, doi. 10.1007/s41669-023-00439-6
- By:
- Publication type:
- Article
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 975, doi. 10.1007/s41669-023-00438-7
- By:
- Publication type:
- Article
The EQ-5D-3L Valuation Study in Pakistan.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 963, doi. 10.1007/s41669-023-00437-8
- By:
- Publication type:
- Article
Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 951, doi. 10.1007/s41669-023-00436-9
- By:
- Publication type:
- Article
Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 941, doi. 10.1007/s41669-023-00435-w
- By:
- Publication type:
- Article
Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 877, doi. 10.1007/s41669-023-00433-y
- By:
- Publication type:
- Article
Hospital Resource Utilization and Costs in Patients with Heart Failure in France.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 927, doi. 10.1007/s41669-023-00431-0
- By:
- Publication type:
- Article
Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality.
- Published in:
- PharmacoEconomics - Open, 2023, v. 7, n. 6, p. 1007, doi. 10.1007/s41669-023-00428-9
- By:
- Publication type:
- Article